SAN DIEGO, January 20, 2026--(BUSINESS WIRE)--Crown Bioscience, a global contract research organization (CRO) and a JSR Life Sciences company, today announced that its San Diego laboratory has ...
SAN DIEGO, October 30, 2025--(BUSINESS WIRE)--Crown Bioscience, a global contract research organization (CRO) headquartered in the United States and part of JSR Life Sciences and Japan-based JSR ...
SAN DIEGO--(BUSINESS WIRE)--Crown Bioscience, a global contract research organization (CRO) and JSR Life Sciences company, today announced the opening of a new site in Singapore to expand the ...
Revance Therapeutics (NASDAQ:RVNC) fell 11% as the deadline for Crown Laboratories tender offer is set to expire on Friday. Crown Labs has extended the tender offer deadline a few times, most recently ...
(RTTNews) - Revance Therapeutics, Inc. (RVNC) disclosed on Monday that it has entered into a merger agreement with Crown Laboratories, Inc., which plans to purchase all outstanding shares of Revance's ...
Crown Bioscience, a global contract research organization (CRO) headquartered in the United States and part of JSR Life Sciences and Japan-based JSR Corporation, today announced that its Suzhou, China ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results